Now part of PerkinElmer, Cisbio develops and markets products and technologies used for in vitro diagnostics and drug discovery. With the proprietary technology, HTRF®, the organization is a leader in homogeneous fluorescence detection methods, and offers first-class assays and services for drug discovery researchers. In addition, Cisbio Bioassays provides a broad range of immunoassays for in vitro diagnostics, mainly tailored for cancerous pathologies, as well as metabolic and auto-immune diseases. Based in Codolet, France, Cisbio owns facilities in Bedford, MA, U.S.A., in Chiba, Japan and Shanghai, China, and markets its offering globally.